Middle East and Africa Kidney Disease Market is expected to reach US$ 7,406.2 Mn by 2027

Hospital Segment Held Largest Share of End-User in Middle East & Africa Kidney Disease Market in 2019

According to The Insight Partners market research study of ‘Middle East & Africa Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Analysis by product, and end-user’ the Middle East & Africa kidney disease market is expected to reach US$ 7,406.2 s 2019. The market is estimated to grow with a CAGR of 5.5% from 2020-2027. The report provides trends prevailing in the Middle East & Africa kidney disease market and the factors driving market along with those that act as hindrances.

Based on the end-user, the Middle East & Africa the kidney disease market, is segmented into hospital, diagnostic laboratories, and others. The hospital segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. Hospitals are the primary healthcare centers where the kidney diseases are extensively treated. These facility centers provide advantages presence of integrated healthcare facilities, the availability of technologically advanced infrastructures, and the ability to perform complex procedures. In addition, the availability of favorable reimbursement policies influences the increasing number of kidney disease treatment procedures. Moreover, the faster development of healthcare infrastructure facilities and a surge in healthcare spending in developing regions is expected to drive the hospitals segment’s growth over the forecast period.

The growth of this market is estimated to grow owing to key driving factors such as rising prevalence of diabetes resulting in renal diseases and rising incidences of renal diseases. However, the market is expected experiencing slow growth during the forecast period owing to the constraint of finance and resources in developing countries.

Pfizer Inc., Teva Pharmaceutical Industries Ltd, Amgen Inc. are among the leading companies operating in the Middle East & Africa kidney disease market. 

Middle East & Africa Kidney Disease Market, By Country, 2019 (% share)

---

Middle East and Africa Kidney Disease Market to Grow at a CAGR of 5.5% to reach US$ 7,406.2 Million from 2020 to 2027

Download Free Sample

---

Middle East and Africa Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Diagnosis and Treatment); End User (Hospitals, Diagnostic Laboratories, and Others); and Country

The report segments Middle East & Africa Kidney Disease Market as Follows:

By Product

• Diagnosis
  • Blood Tests
  • Urine Tests
  • Imaging Tests
  • Others
• Treatment
  • Dialysis
  • Others
  • Drug Class
    • ACE Inhibitors
    • Angiotensin-II Receptor Blockers
    • Diuretics
    • Others

By End User

• Hospitals
• Diagnostic Laboratories
• Others

By Country

• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa